{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T05:36:10Z","timestamp":1779255370499,"version":"3.51.4"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,10,30]],"date-time":"2020-10-30T00:00:00Z","timestamp":1604016000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,30]],"date-time":"2020-10-30T00:00:00Z","timestamp":1604016000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"published-print":{"date-parts":[[2021,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p>To develop a risk predictor model in evaluation of tomosynthesis-detected architectural distortion (AD) based on characteristics of contrast-enhanced digital mammography (CEDM).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Ninety-four AD lesions on CEDM in combination with tomosynthesis were retrospectively reviewed from 92 consecutive women (mean age, 52.4\u00a0years \u00b1\u20097.9) with abnormal diagnostic or screening mammography. CEDM results were correlated with histology of ADs using cross-tabulation for statistical analysis. Predictors for risk of malignancy from CEDM characteristics (background parenchyma enhancement, degree of AD enhancement, enhancing morphology, size of enhancement, and enhancing spiculations) and patient\u2019s age were evaluated using logistic regression. We propose a sum score, termed AD score (ADS), for risk stratification and corresponding suggested BI-RADS category.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Thirty-three of ninety-four (35.1%) of detected AD lesions were malignant. The sensitivity, specificity, PPV, and NPV of CEDM in evaluation of malignant AD are 100%, 42.6%, 48.5%, and 100%, respectively. Absence of AD enhancement on CEDM is highly indicative of no underlying malignancy. On multivariate analysis, the predictors on CEDM with statistical significance are (1) marked intensity of AD enhancement (OR, 22.6; 95%CI 3.1, 166.6; <jats:italic>p<\/jats:italic>\u2009=\u2009.002); and (2) presence of enhancing spiculations (OR, 9.1; 95%CI 2.2, 36.5; <jats:italic>p<\/jats:italic>\u2009=\u2009.002). A prediction model whose scores (ADS) given by ranking of OR of all predictors with AUC of 0.934 and Brier score of 0.0956 was developed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>ADS-based lesion characterization on CEDM enables risk assessment of tomosynthesis-detected AD lesions.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Key Points<\/jats:title>\n                <jats:p><jats:italic>\u2022 Architecture distortions presenting with marked enhancement intensity and presence of enhancing spiculations are highly associated with risk of malignancy.<\/jats:italic><\/jats:p>\n                <jats:p><jats:italic>\u2022 Absence of architecture distortion enhancement in minimal or mild background parenchyma enhancement on CEDM indicates low risk of breast malignancy (NPV\u2009=\u2009100%).<\/jats:italic><\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00330-020-07395-3","type":"journal-article","created":{"date-parts":[[2020,10,30]],"date-time":"2020-10-30T06:02:41Z","timestamp":1604037761000},"page":"2657-2666","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Architecture distortion score (ADS) in malignancy risk stratification of architecture distortion on contrast-enhanced digital mammography"],"prefix":"10.1007","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3149-0295","authenticated-orcid":false,"given":"Yonggeng","family":"Goh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ching Wan","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Premilla","family":"Pillay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herng-Sheng","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huay-Ben","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bao-Hui","family":"Hung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Swee Tian","family":"Quek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen-Pin","family":"Chou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,10,30]]},"reference":[{"issue":"5","key":"7395_CR1","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/S0025-6196(12)60194-3","volume":"68","author":"AM Knutzen","year":"1993","unstructured":"Knutzen AM, Gisvold JJ (1993) Likelihood of malignant disease for various categories of mammographically detected, nonpalpable breast lesions. Mayo Clin Proc 68(5):454\u2013460","journal-title":"Mayo Clin Proc"},{"key":"7395_CR2","doi-asserted-by":"crossref","unstructured":"Venkatesan A, Chu P, Kerlikowske, Sickles EA, Smith-Bindman R (2009) Positive predictive value of specific mammographic findings according to reader and patient variables. Radiology 250(3):648\u2013657","DOI":"10.1148\/radiol.2503080541"},{"key":"7395_CR3","doi-asserted-by":"crossref","unstructured":"Geller BM, Barlow WE, Ballard-Barbash R, et al (2002) Use of the American College of Radiology BI-RADS to report on the mammographic evaluation of women with signs and symptoms of breast disease. Radiology 222(2):536\u2013542","DOI":"10.1148\/radiol.2222010620"},{"key":"7395_CR4","doi-asserted-by":"crossref","unstructured":"Shaheen R, Schimmelpenninck CA, Stoddart L, Raymond H, Slanetz PJ (2011) Spectrum of diseases presenting as architectural distortion on mammography: multimodality radiologic imaging with pathologic correlation. Semin Ultrasound CT MR 32(4):351\u2013362","DOI":"10.1053\/j.sult.2011.03.008"},{"key":"7395_CR5","doi-asserted-by":"crossref","unstructured":"Bahl M, Baker JA, Kinsey EN, Ghate SV (2015) Architectural distortion on mammography: correlation with pathologic outcomes and predictors of malignancy. AJR Am J Roentgenol 205(6):1339\u20131345","DOI":"10.2214\/AJR.15.14628"},{"issue":"1","key":"7395_CR6","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1148\/radiol.2018171159","volume":"288","author":"TI Alshafeiy","year":"2018","unstructured":"Alshafeiy TI, Nguyen JV, Rochman CM et al (2018) Outcome of architectural distortion detected only at breast tomosynthesis versus 2D mammography. Radiology 288(1):38\u201346","journal-title":"Radiology"},{"issue":"5","key":"7395_CR7","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.2214\/AJR.17.17979","volume":"209","author":"M Bahl","year":"2017","unstructured":"Bahl M, Lamb LR, Lehman CD (2017) Pathologic outcomes of architectural distortion on digital 2D versus tomosynthesis mammography. AJR Am J Roentgenol 209(5):1162\u20131167","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"7395_CR8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00330-017-4968-8","volume":"28","author":"EH Dibble","year":"2018","unstructured":"Dibble EH, Lourenco AP, Baird GL et al (2018) Comparison of digital mammography and digital breast tomosynthesis in the detection of architectural distortion. Eur Radiol 28(1):3\u201310","journal-title":"Eur Radiol"},{"key":"7395_CR9","doi-asserted-by":"crossref","unstructured":"Buchberger W, DeKoekkoek-Doll P, Obrist P, D\u00fcnser M (1997) Value of MR tomography in inconclusive mammography findings. Radiologe 37(9):702\u2013709","DOI":"10.1007\/s001170050271"},{"issue":"3","key":"7395_CR10","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1148\/radiology.191.3.8184038","volume":"191","author":"R Gilles","year":"1994","unstructured":"Gilles R, Guinebretiere JM, Lucidarme O et al (1994) Nonpalpable breast tumors: diagnosis with contrast-enhanced subtraction dynamic MR imaging. Radiology 191(3):625\u2013631","journal-title":"Radiology"},{"key":"7395_CR11","doi-asserted-by":"crossref","unstructured":"Si L, Zhai R, Liu X, Yang K, Wang L, Jiang T (2016) MRI in the differential diagnosis of primary architectural distortion detected by mammography. Diagn Interv Radiol 22(2):141\u2013150","DOI":"10.5152\/dir.2016.15017"},{"issue":"3","key":"7395_CR12","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1148\/radiol.12121084","volume":"266","author":"MS Jochelson","year":"2013","unstructured":"Jochelson MS, Dershaw DD, Sung JS et al (2013) Bilateral contrast-enhanced dual-energy digital mammography: feasibility and comparison with conventional digital mammography and MR imaging in women with known breast carcinoma. Radiology 266(3):743\u2013751","journal-title":"Radiology"},{"issue":"2","key":"7395_CR13","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.diii.2016.08.013","volume":"98","author":"L Li","year":"2017","unstructured":"Li L, Roth R, Germaine P et al (2017) Contrast-enhanced spectral mammography (CESM) versus breast magnetic resonance imaging (MRI): a retrospective comparison in 66 breast lesions. Diagn Interv Imaging 98(2):113\u2013123","journal-title":"Diagn Interv Imaging"},{"issue":"5","key":"7395_CR14","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1245\/s10434-018-6413-x","volume":"25","author":"BK Patel","year":"2018","unstructured":"Patel BK, Hilal T, Covington M et al (2018) Contrast-enhanced spectral mammography is comparable to MRI in the assessment of residual breast cancer following neoadjuvant systemic therapy. Ann Surg Oncol 25(5):1350\u20131356","journal-title":"Ann Surg Oncol"},{"key":"7395_CR15","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.clinimag.2016.12.011","volume":"42","author":"J Phillips","year":"2017","unstructured":"Phillips J, Miller MM, Mehta TS et al (2017) Contrast-enhanced spectral mammography (CESM) versus MRI in the high-risk screening setting: patient preferences and attitudes. Clin Imaging 42:193\u2013197","journal-title":"Clin Imaging"},{"key":"7395_CR16","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.breast.2020.06.005","volume":"53","author":"MB Suter","year":"2020","unstructured":"Suter MB, Pesapane F, Agazzi GM et al (2020) Diagnostic accuracy of contrast-enhanced spectral mammography for breast lesions: a systematic review and meta-analysis. Breast 53:8\u201317","journal-title":"Breast"},{"key":"7395_CR17","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.clinimag.2017.07.003","volume":"46","author":"BK Patel","year":"2017","unstructured":"Patel BK, Naylor ME, Kosiorek HE et al (2017) Clinical utility of contrast-enhanced spectral mammography as an adjunct for tomosynthesis-detected architectural distortion. Clin Imaging 46:44\u201352","journal-title":"Clin Imaging"},{"key":"7395_CR18","doi-asserted-by":"crossref","unstructured":"Durand MA, Wang S, Hooley RJ, Raghu M, Philpotts LE (2016) Tomosynthesis-detected architectural distortion: management algorithm with radiologic-pathologic correlation. Radiographics 36(2):311\u2013321","DOI":"10.1148\/rg.2016150093"},{"key":"7395_CR19","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.clinimag.2019.01.004","volume":"54","author":"AC Pujara","year":"2019","unstructured":"Pujara AC, Hui J, Wang LC (2019) Architectural distortion in the era of digital breast tomosynthesis: outcomes and implications for management. Clin Imaging 54:133\u2013137","journal-title":"Clin Imaging"},{"key":"7395_CR20","doi-asserted-by":"crossref","unstructured":"Vijapura C, Yang L, Xiong J, Fajardo LL (2018) Imaging features of nonmalignant and malignant architectural distortion detected by tomosynthesis. AJR Am J Roentgenol 211(6):1397\u20131404","DOI":"10.2214\/AJR.18.19658"},{"key":"7395_CR21","doi-asserted-by":"crossref","unstructured":"Giess CS, Chikarmane SA, Sippo DA, Birdwell RL (2017) Clinical utility of breast MRI in the diagnosis of malignancy after inconclusive or equivocal mammographic diagnostic evaluation. AJR Am J Roentgenol 208(6):1378\u20131385","DOI":"10.2214\/AJR.16.16751"},{"key":"7395_CR22","doi-asserted-by":"crossref","unstructured":"Macura KJ, Ouwerkerk R, Jacobs MA, Bluemke DA (2006) Patterns of enhancement on breast MR images: interpretation and imaging pitfalls. Radiographics 26(6):1719\u20131734 quiz 1719","DOI":"10.1148\/rg.266065025"},{"issue":"11","key":"7395_CR23","doi-asserted-by":"publisher","first-page":"6220","DOI":"10.1007\/s00330-019-06232-6","volume":"29","author":"W Rudnicki","year":"2019","unstructured":"Rudnicki W, Heinze S, Niemiec J et al (2019) Correlation between quantitative assessment of contrast enhancement in contrast-enhanced spectral mammography (CESM) and histopathology-preliminary results. Eur Radiol 29(11):6220\u20136226","journal-title":"Eur Radiol"},{"issue":"2","key":"7395_CR24","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1148\/radiology.219.2.r01ma44484","volume":"219","author":"LW Nunes","year":"2001","unstructured":"Nunes LW, Schnall MD, Orel SG (2001) Update of breast MR imaging architectural interpretation model. Radiology 219(2):484\u2013494","journal-title":"Radiology"},{"key":"7395_CR25","doi-asserted-by":"crossref","unstructured":"Hambly NM, Liberman L, Dershaw DD, Brennan S, Morris EA (2011) Background parenchymal enhancement on baseline screening breast MRI: impact on biopsy rate and short-interval follow-up. AJR Am J Roentgenol 196(1):218\u2013224","DOI":"10.2214\/AJR.10.4550"},{"issue":"11","key":"7395_CR26","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1007\/s00330-011-2175-6","volume":"21","author":"T Uematsu","year":"2011","unstructured":"Uematsu T, Kasami M, Watanabe J (2011) Does the degree of background enhancement in breast MRI affect the detection and staging of breast cancer? Eur Radiol 21(11):2261\u20132267","journal-title":"Eur Radiol"},{"issue":"2","key":"7395_CR27","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1007\/s00330-017-5011-9","volume":"28","author":"A Vourtsis","year":"2018","unstructured":"Vourtsis A, Kachulis A (2018) The performance of 3D ABUS versus HHUS in the visualisation and BI-RADS characterisation of breast lesions in a large cohort of 1,886 women. Eur Radiol 28(2):592\u2013601","journal-title":"Eur Radiol"},{"issue":"1","key":"7395_CR28","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jacr.2009.09.022","volume":"7","author":"CH Lee","year":"2010","unstructured":"Lee CH, Dershaw DD, Kopans D et al (2010) Breast cancer screening with imaging: recommendations from the Society of Breast Imaging and the ACR on the use of mammography, breast MRI, breast ultrasound, and other technologies for the detection of clinically occult breast cancer. J Am Coll Radiol 7(1):18\u201327","journal-title":"J Am Coll Radiol"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-020-07395-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00330-020-07395-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-020-07395-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T10:31:30Z","timestamp":1618309890000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00330-020-07395-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,30]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["7395"],"URL":"https:\/\/doi.org\/10.1007\/s00330-020-07395-3","relation":{},"ISSN":["0938-7994","1432-1084"],"issn-type":[{"value":"0938-7994","type":"print"},{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,30]]},"assertion":[{"value":"30 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The scientific guarantor of this publication is Dr. Goh Yonggeng.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Dr. Chan Yiong Huak and Ms. Yap Qai Wen from the National University of Singapore (NUS) Medicine Biostatistics Unit kindly provided statistical advice for this manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistics and biometry"}},{"value":"Written informed consent was waived by the Institutional Review Board.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Institutional Review Board approval was obtained.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"\u2022 retrospective\u2022 cross-sectional study\u2022 performed at one institution","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Methodology"}}]}}